The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
HdX6EY6F7SpmC8dk
